NURIX THERAPEUTICS INC (NRIX:NASDAQ)
$16.44 -0.6 (-3.5211%)
Analysed NURIX THERAPEUTICS INC (NRIX:NASDAQ) News Sources
Wells Fargo Cuts PT on Nurix Therapeutics (NRIX) to $28 From $29
20-04-2026
yahoo.com
Did Sanofi Revenue Expiry and Rising R&D Spend Just Recast Nurix Therapeutics' (NRIX) Investment Narrative?
11-04-2026
yahoo.com
Does Nurix Therapeutics (NRIX) Have the Potential to Rally 85.84% as Wall Street Analysts Expect?
10-04-2026
yahoo.com
Company News for Apr 9, 2026
09-04-2026
yahoo.com
Nurix Therapeutics, Inc. (NRIX) Reports Q1 Loss, Lags Revenue Estimates
08-04-2026
yahoo.com
Nurix Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update
08-04-2026
yahoo.com
Nurix Therapeutics to Participate in Upcoming Investor Conference
07-04-2026
yahoo.com
A Look At Nurix Therapeutics (NRIX) Valuation After Strong 1 Year Return And High Price To Sales Ratio
04-04-2026
yahoo.com
Alpha Cognition Inc. (ACOG) Reports Q4 Loss, Lags Revenue Estimates
26-03-2026
yahoo.com
Nurix Therapeutics (NRIX) Moves 6.9% Higher: Will This Strength Last?
26-03-2026
yahoo.com
What is the current price of NURIX THERAPEUTICS INC (NRIX:NASDAQ)?
The current price of NURIX THERAPEUTICS INC (NRIX:NASDAQ) is $16.44.
NURIX THERAPEUTICS INC (NRIX:NASDAQ) absolute price change since previous trading day?
The absolute price change of NURIX THERAPEUTICS INC (NRIX:NASDAQ) since the previous trading day is $-0.6.
NURIX THERAPEUTICS INC (NRIX:NASDAQ) percentage price change since previous trading day?
The percentage price change of NURIX THERAPEUTICS INC (NRIX:NASDAQ) since the previous trading day is -3.5211%.
What is the most recent average sentiment score for NURIX THERAPEUTICS INC (NRIX:NASDAQ)?
The most recent average sentiment score for NURIX THERAPEUTICS INC (NRIX:NASDAQ) is 74 out of 100.
What is the most recent average sentiment for NURIX THERAPEUTICS INC (NRIX:NASDAQ)?
The most recent sentiment for NURIX THERAPEUTICS INC (NRIX:NASDAQ) is .
SEC-8K** Filing Available For NURIX THERAPEUTICS INC (NRIX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.